HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
University of Calgary
University of Calgary
National Institutes of Health Clinical Center (CC)
Beijing University of Chinese Medicine
City of Hope Medical Center
Latin American Cooperative Oncology Group
Fondazione Italiana Linfomi - ETS
Gødstrup Hospital
University Hospital, Bordeaux
Astellas Pharma Inc
AstraZeneca
Exscientia AI Limited
Novartis
Bristol-Myers Squibb
Hospital del Mar
Cancer Trials Ireland
National Institutes of Health Clinical Center (CC)
Astellas Pharma Inc
Parc de Salut Mar
Regeneron Pharmaceuticals
Celgene
Maastricht University Medical Center
Celgene
Celgene
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Charles University, Czech Republic
Immatics US, Inc.
Pfizer
Duke University
IRCCS Azienda Ospedaliero-Universitaria di Bologna
European Hepatocellular Cancer Liver Transplant Group
Bristol-Myers Squibb
Bayer
Hospital Universitari de Bellvitge
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
St. Jude Children's Research Hospital
Hospital de Granollers
Anhui Medical University
Fujian Medical University
Zagazig University
Tongji Hospital
Wroclaw Medical University
Celgene
University Hospital Plymouth NHS Trust
AbbVie
Regeneron Pharmaceuticals
AbbVie
Severance Hospital
ARCAGY/ GINECO GROUP
AIDS Malignancy Consortium
Zhejiang University